tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ITRM Stock Latest News

Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
RatingsIterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
10d ago
ITRM
Iterum Therapeutics Partners with Eversana for US Launch
PremiumCompany Announcements
Iterum Therapeutics Partners with Eversana for US Launch
11d ago
8K
ITRM
Iterum Therapeutics announces partnership for commercialization services
PremiumThe Fly
Iterum Therapeutics announces partnership for commercialization services
11d ago
ITRM
Iterum Therapeutics Extends Milestone Payment Terms with Pfizer
PremiumCompany Announcements
Iterum Therapeutics Extends Milestone Payment Terms with Pfizer
1M ago
8K
ITRM
Iterum Therapeutics announces extension of term of promissory note
PremiumThe Fly
Iterum Therapeutics announces extension of term of promissory note
1M ago
PFE
ITRM
Iterum Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsIterum Therapeutics’ Earnings Call: Progress Amid Challenges
1M ago
ITRM
Buy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
Premium
Ratings
Buy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
1M ago
ITRM
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
Premium
Company Announcements
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
1M ago
ITRM
Iterum Therapeutics: Strategic Positioning and Financial Stability Justify Buy Rating
PremiumRatings
Iterum Therapeutics: Strategic Positioning and Financial Stability Justify Buy Rating
1M ago
ITRM
Iterum Therapeutics reports Q1 non-GAAP EPS (10c) vs. (38c) last year
PremiumThe Fly
Iterum Therapeutics reports Q1 non-GAAP EPS (10c) vs. (38c) last year
1M ago
ITRM
Iterum Therapeutics sees cash runway into 2026
PremiumThe Fly
Iterum Therapeutics sees cash runway into 2026
1M ago
ITRM
Is ITRM a Buy, Before Earnings?
PremiumPre-Earnings
Is ITRM a Buy, Before Earnings?
1M ago
ITRM
Iterum Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe FlyIterum Therapeutics assumed with a Buy at H.C. Wainwright
1M ago
ITRM
Iterum Therapeutics prices 5.56M shares at 90c in registered direct offering
Premium
The Fly
Iterum Therapeutics prices 5.56M shares at 90c in registered direct offering
2M ago
ITRM
Iterum Therapeutics Appoints New Board Members
Premium
Company Announcements
Iterum Therapeutics Appoints New Board Members
3M ago
8K
ITRM
Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH™ Despite FDA Approval
PremiumCompany Announcements
Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH™ Despite FDA Approval
4M ago
ITRM
Iterum Therapeutics Highlights FDA Approval and Financial Progress
PremiumCompany Announcements
Iterum Therapeutics Highlights FDA Approval and Financial Progress
4M ago
ITRM
Iterum Therapeutics Highlights FDA Approval and Market Potential
PremiumCompany Announcements
Iterum Therapeutics Highlights FDA Approval and Market Potential
4M ago
ITRM
Iterum Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Iterum Therapeutics files $150M mixed securities shelf
4M ago
ITRM
Morning Movers: Amazon slips after soft revenue guidance, big AI spending plans
PremiumThe FlyMorning Movers: Amazon slips after soft revenue guidance, big AI spending plans
4M ago
UI
CGC
Iterum Therapeutics reports Q4 non-GAAP EPS (12c) vs. (81c) last year
Premium
The Fly
Iterum Therapeutics reports Q4 non-GAAP EPS (12c) vs. (81c) last year
4M ago
ITRM
Iterum Therapeutics sees cash runway into 2H25
Premium
The Fly
Iterum Therapeutics sees cash runway into 2H25
4M ago
ITRM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >